Diazepam nasal spray is Japan's first nasally administered antiepileptic that has demonstrated efficacy and safety in Phase 3 clinical trials in Japan for the treatment of status epilepticus or epileptic seizures that may lead to status epilepticus.
Aculys is a Japan-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of neurological and psychiatric diseases.